![](https://vdilab.com/wp-content/uploads/2019/12/1920x1080c.jpg)
Biomarker for Cancer
Clinical Applications and Research
![](https://vdilab.com/wp-content/uploads/2019/12/GBE_TK1-791x1024.jpg)
We’re excited to bring you the newest Growing Body of Evidence: Thymidine Kinase.
Research in support of TK1 as a biomarker for cancer detection and monitoring continues to mount. The Growing Body of Evidence provides a summary of that research, and applications for use in your practice.
Click to download, or learn more below.
TK1 is available in the following tests/panels from VDI:
- Wellness Panels + Cancer Risk
- Canine Cancer Panel
- Pericardial Effusion Panel (PCE)
- Feline Cancer Panel
- Pre-Stem Cell Therapy Panel
- Equine TK1
CLINICAL APPLICATIONS
![](https://vdilab.com/wp-content/uploads/2019/12/AdobeStock_171478945-300x286.jpeg)
Canine:
- Lymphoma
- Abdominal Masses
- Hypercalcemia of malignancy
- ADR
- Stem Cell Therapy
- Metastatic Disease
- Therapeutic Monitoring
- Pericardial Effusion Tumor Dx
- Wellness Screening
![](https://vdilab.com/wp-content/uploads/2019/12/AdobeStock_180446708-231x300.jpeg)
Feline:
- GI Lymphoma vs IBD
- Therapeutic Monitoring
- Metastatic Disease
Equine:
- Lymphoma